© Copyright Nostre Net
Market Insights
The medical
imaging market size was valued USD 39.19 in 2021 and is expected to reach
USD 64.99 billion by 2030 at 7.10% CAGR during the forecast period 2022-2030;
this and other vital market figures have been revealed in Market Research
Future's detailed report on the subject. Advancements in technology have
introduced medical imaging systems that can show diffuse and focal pathologies
in a variety of organs.
Increasing prevalence of various chronic diseases, cardiac
diseases, and neurological diseases have resulted in increased demand for
medical imaging services. Healthcare as a sector is growing exponentially
across the world, with increasing investments being made in state of the art
systems. Emerging economies are expected to make huge development in catching
up to developed economies with regards to providing patients with advanced
systems which are widely available. Several market leaders are involved in
comprehensive research and development activities to offer further advancements
in the highly competitive market. Additionally, there is a high preference and
demand for minimally invasive treatments and diagnostic procedures. This combined
with rising numbers of diagnostic imaging centers are likely to lead to surging
growth for the global medical imagining market.
Presently, health care reforms have not caught up to
healthcare trends, particularly in emerging and underdeveloped economies which
will pose a challenge to the growth of the market. Moreover, medical imaging
devices are expensive. However, emerging economies represent high promise and
opportunities for growth in the coming years, and R&D activities will
likely expand market value.
Market Segmentation
The Global Medical
Imaging Market insights is segmented based on product type, application,
end-user, and region. By product type, the market is segmented into magnetic
resonance imaging (MRI), X-Ray imaging systems, ultrasound imaging systems,
nuclear imaging systems, and computed tomography (CT) scanners. The MRI segment
is sub-segmented into low to mid-field MRI systems, high and very high field
MRI systems, and ultra-high field MRI systems. Other sub-segmentations of key
segments are provided in the report.
By application, the market is segmented into product type,
and then further segmented by applications for each product type. Key segments
include MRI systems, CT scanners, nuclear imaging systems, X-ray imaging
systems, and ultrasound imaging systems. ultrasound systems are further
segmented into obstetrics, general imaging, cardiology, urology, vascular, and
others. Further sub-segmentation can be found in the report.
By end-user, the market is segmented into hospitals &
clinics, research & academic institutes, diagnostic imaging centers, and
others.
Regional Analysis
The Americas, with their inclusion of North America, account
for the most significant share of the global medical imaging market. The
presence of a developed healthcare sector, swift adoption of technological
advancements and the regions role in advancing the market are significant
factors responsible for it's leading market position. Europe is the second most
significant region due to high government support for advanced healthcare being
made available to the regions patient population.
Meanwhile, the APAC market has a rapidly developing healthcare
sector with the government's full support. The region is advancing rapidly in
its adoption and demand for advanced healthcare and is expected to be a
significant market in the future.
Key Players
Profiled market players include Samsung Medison, Toshiba
Corporation, Narang Medical Limited, Fonar Corporation, Hologic Inc., Shimadzu
Corporation, Fujifilm Holdings Corporation, Siemens AG, General Electric
Company, Hitachi Ltd., Carestream Health, Esaote S.P.A, and Koninklijke Philips
N.V.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Highlights
The structural
health monitoring market trends is projected to reach USD 4.3 Billion at
CAGR of 15% from 2022 to 2030.The global Structural Health Monitoring market is
projected to record a CAGR of ~15% during the forecast period. Structural Health Monitoring is a type of
monitoring that will detect if there are any damages to the structures.
Structural health monitoring can be applied to many different types of
structures such as buildings, bridges, and pipelines. It can also be used on
other objects such as aircraft and ships.
The COVID-19 outbreak has significantly impacted the global
economy by disrupting production and demand, impacting the supply chain in the
market. The government put a contingency plan in place by putting people inside
their houses with no contact with the outside world. The government imposed a
country-wide lockdown to minimize the risk of any further outbreaks.
There was a decrease in the demand for structural health
monitoring market. During this pandemic, people were focusing on necessary
items and were avoiding the unnecessary costs. This has decreased the demand
for infrastructure projects. Furthermore, the government stopped all
unnecessary activities that have stopped various construction and infrastructure
projects.
Market Research Future has recognized the following
companies as the key players in the global Structural Health Monitoring market
Nova Metrix LLC, Geokon, Campbell Scientific, COWI, Geocomp, Acellent
Technologies, Sixense, Pure Technologies, Structural Monitoring Systems, SGS,
and Digi-Texx among others.
Segmental Analysis
The global structural health monitoring market has been
segmented based on offering, technology, end-use, and region. By offering, the
global structural health monitoring market has been segmented into hardware,
software & services. The software & services segment is anticipated to
witness rapid growth in the global structural health monitoring market. As soon
as the data arrives at the sensors, the software starts monitoring and
analyzing its structure. The software provides the visual representation of the
data on structural behavior and allows people to see the changes in real-time
so that damages can be detected at the earliest. To do this, structures need to
be monitored regularly. Structural health monitoring is crucial for any project
with a large infrastructure. Structural failures are also increasing
frequently, which is why this technology has become more urgent. To ensure the
health and integrity of various structures and systems, one can use an approach
based on the data collection from sensors installed around the building or
machine. These include parameters related to loading, stress, strain and
acceleration. Furthermore, it can be challenging for structural engineers to
process and analyze such high volumes of data. To get around this, software
platforms, apps, and other coding solutions are being adopted.
Based on the end-use, the global structural health
monitoring market has been segmented based on civil infrastructure, aerospace
& defense, energy, mining, and others. The civil Infrastructure segment is
expected to be the largest revenue generating segment in the global structural
health monitoring market. The civil infrastructure segment includes bridges,
tunnels, dams, buildings & stadiums. Countries have been investing in
physical infrastructure for a long time now. The US, the UK, Japan, Germany,
and other countries have been making increasingly large investments in this
area as they recognize the potential on offer. It is a positive step towards
future economic growth. Rapid urbanization and an urgent need for high-quality
infrastructure are driving the growth of the world civil infrastructure market.
This brings the increasing number of civil infrastructure projects, which are
set to create a high demand for structural health monitoring systems. In other
words, these systems can be used to maintain and monitor the condition of each
structure and avoid catastrophic failures.
Regional Analysis
Geographically, the global structural
health monitoring market report has been categorized as North America,
Europe, Asia-Pacific, and Rest of the World. In recent years, the North
American market has seen enormous development in the structural health
monitoring sector. Structural health monitoring has been transforming the way
buildings are built and sustained. Companies have been using this service to
detect and prevent structural issues such as building collapse, fire, or
structural failure that can cost thousands of dollars to repair.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
According to MRFR analysis, the global downstream
processing market trends is expected to register a CAGR of~16.09% from 2021
to 2027and hold a value of ~USD 61,174.53million by 2027.
Downstream processing refers to the series
of operations required to derive pure and homogeneous protein products from
biological materials such as cells, tissue culture fluid, or plant tissues.
There is a high demand for the end products extracted by downstream processing,
owing to the increasing applicationsin biopharmaceutical products. Thus, the downstream
processing market is anticipated to observe significant growth during the
forecast period.
Many market players are dominating the
global downstream processing market. The prominent players are involved in
strategic agreements,new product launches& developments,joint ventures,
partnerships, collaborations, mergers & acquisitions, geographic
expansionto sustaintheir market positions.For instance, in March 2021, Thermo
Fisher Scientific, Inc. (US) announced that more than USD 600 million would be
invested to expand its bioprocessing production capabilities through 2022 to
meet short-term demands related to COVID-19 as well as long-term efforts to
improve new vaccines and biologics for other conditions.
Key Players
Some of the key players in the global
downstream processing market are Thermo Fisher Scientific Inc. (US), Sartorius
Stedim Biotech S.A. (France), Merck Millipore (Germany), Danaher Corporation
(US), 3M Company (US), Boehringer Ingelheim (Germany), Lonza Group AG
(Switzerland), Eppendorf AG (Switzerland), Corning Incorporated (US), and Asahi
Kasei Corporation (Japan).
Segmentation
The global downstream processing market has
been segmented into technique, product, application, and end user.
By technique, the market has been
segregated into cell disruption, solid-liquid separation, clarification/concentration,
downstream purification techniques, and formulation. The purification
techniques segment is further sub-segmented into ion exchange, affinity
exchange, hydrophobic interaction, size exclusion chromatography, and others.
The purification techniques segment held a significant share of the market in
2020, as it isone of the vital steps in downstream processing and has high
product differentiation.
Based on the product, the global downstream
processing market has been classified as chromatography columns &resins,
filters, membrane adsorbers, and others. The chromatography columns
&resinsis one of the most widely used product andwasestimated to bethe
largest segment in 2020.
Based on application, the downstream
processing market is segmented into antibiotic production, hormone production,
antibodies production, vaccine production, and others. Antibiotic productionis
one of the vital applications owing to increasing infectious diseases.
Furthermore, the ongoing pandemic has created a huge demand for vaccine
production globally which further supports the growth of the market.
Based on the end user, the downstream processing
market is segmented into biopharmaceutical manufacturers, contract
manufacturing organizations, and others. The biopharmaceutical manufacturers
segment held the largest market share in 2020 due to increased R&D
activities and production of biologics at a largescale, along with the rapidly
growing biopharmaceutical industry.
Regional Analysis
By region, North America is anticipated to
dominate the global downstream
processing market report, owing to well-established research organizations
involved in research activities, the presence of a high number of contract
manufacturing organizations (CMOs), and the presence of a largenumber of
pharmaceutical and biopharmaceutical companies. Moreover, the rise in R&D
investments by public and private players in the healthcare sectorfurther
drives the market growth.
On the other hand, the European downstream
processing market is driven by rising R&D expenditure by biopharmaceutical
companies, increasing investments in the R&D sector, and the presence of
key market players. For instance, in November 2019, Thermo Fisher Scientific,
Inc. (US) announced that it is investing nearly USD 24 million in its Scotland
site to expand global bioproduction capabilities with additional large-volume
liquid manufacturing capacity for cell culture media.
Asia-Pacific is anticipated to be the
fastest-growing market in the region over the assessment period due to growing
and improving healthcare infrastructure, the establishment of research
organizations, and increasing investments in biotechnology. In addition,
factors such as the growing investments by key market players and the rapidly
developing pharma and biopharma sector in the region are further driving the
market.For instance, in April 2021, Asahi Kasei Corporation, a solution provider
to the biologics manufacturing industry, expanded its business in China with
the launch of Asahi Kasei Bioprocess (Shanghai) Co., Ltd (AKBC).The launch of
AKBC facilitates business expansion in China by localizing inventory management
and order processing for shorter delivery times.
Furthermore, the growth of the market in
theRest of the World is attributed to the booming biotechnology sector and
advancements in chromatographic techniques inthe region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Molecular modelling is a strategy that involves
computational techniques that integrates creation, manipulation, and
representation of molecular structures. Based on this technology, a lot of drug
can be developed. This process enables scientists to run various simulations
that can ensure better results for the global drug development market. The
global molecular
modelling market trends is expected to cross USD 1,617.80 million a CAGR of
15.93% during the forecast period 2027. Market Research Future (MRFR) discloses
possibilities that can be explored well in the future to ensure strong growth
in the coming years.
Various factors like hike in research-related investments,
growing impact from pharmaceuticals to discover new drugs, technologies to
develop personalized drug, better healthcare-related investments, growing cases
of chronic disease, hike in budgets for healthcare sector, and other are
expected to influence the global molecular modelling market. The burgeoning
biosimilars and biologics industry is expected to take the market further ahead
in the coming years.
Segmentation:
Product, application, and end-users are segments that have
been included in the global molecular modelling market. This analysis is
expected to provide in-depth analysis of various factors that can be used later
to garner more profits in the coming years.
By product, the molecular modelling market comprises
software and services. The software segment is generating substantial revenue
and is expected to climb up with a 13.55% CAGR. But the services segment is
expected to register the fastest CAGR of 18.64% within the same time
frame.
Based on the application, the global molecular modelling
market can be segmented into drug development, drug discovery, and others. the
drug development segment can step ahead with 13.26% CAGR during the forecast
period. The drug discovery segment is deemed to register the fastest CAGR of
17.30% over the assessment period.
By end-users, the molecular modelling market comprises
research centers & academic institutions, pharmaceutical &
biotechnological companies, and others. The pharmaceutical and biotechnological
companies are expected to register a 13.84% growth during the forecast period,
whereas, the research centers and academic institutions can post a CAGR of
19.16% during the review period.
Regional Analysis:
Region-wise analysis of the global molecular
modelling market report has four specific regions under its coverage. These
regions are the Americas, Europe, Asia Pacific (APAC), and the Middle East and
Africa (MEA). The report is all set to provide better demographic analysis to
assist in the exploration of several possibilities that can impact the market
growth in the future.
Technical superiority, robust infrastructure, high
expenditure capacity, better research & development projects, and other
healthcare-related initiatives are expected to provide strong traction to the
regional market. The Americas is a region that includes two regions, North and
South America. North America has better market scenario than South
America.
Europe is sharing similar features like that of North
America. These two regions are known for their research and development
projects where development of new products and innovations are quite expected.
The region is following North America closely in terms of market valuation.
Several countries like the UK, France, Germany, and others are expected to
promote the regional market.
The APAC market is expecting strong growth in the coming
years with assistance from the hike in the market valuation of China, India,
Thailand, Singapore, and others.
Competitive Landscape:
Prominent market players in the global molecular modelling
market are Schrödinger, LLC, Cresset, Acellera Ltd., BioSolve-IT, Optibrium,
Chemical Computing Group, Simulations Plus, Inc., Cambridge Crystallographic
Data Centre OpenEye Scientific Software, Certara, L.P, Dassault Systèmes, and
others. MRFR included these companies and profiled them for a better analysis
of the global process. Such a report also includes various strategic moves
taken by these companies. These moves are merger, acquisition, collaboration,
and other methods.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
According to MRFR analysis, the global biopharmaceutical
excipients market trends is expected to register a CAGR of~6.8% from 2021
to 2027 and is expected to hold a value of ~USD 3,114.6 million by 2027
The global biopharmaceutical excipients market is driven by
several factors, such as increasing demand for oral formulations across the
globe, rising demand for customized medicines, and an increasing geriatric
population. Other factors such as increasing patients with chronic
ailmentscoupled with growing life expectancy are driving the production of
biopharmaceuticals. In addition, increasing stress, back pains, body aches, and
headaches has augmented the demand for topical type formulation, accelerating
the market growth.
The industry players focus on expanding their global
footprint by strategic partnerships, investing in some company’s stock,
acquisitions, and product launches. For instance, in February 2020, ReForm Biologics
(US) partnered with MilliporeSigma (US) to commercialize excipients used in
biotherapeutics. In August 2019, LBB Specialties (US) announced the strategic
partnership with MEGGLE (Germany)to expand its excipient distribution channel
across the US. In December 2018, Roquette (France) bought a majority stake in
excipient producer Crest Cellose (India) that enabled the company to expand its
product portfolio and presence in the Indian generic pharmaceutical market.
Furthermore, the prominent players focus on new developments, employee
satisfaction, the transformation of their research wings, and expanding their
distribution network. These factors will augment the market growth and will
increase theproduct demand in the forecast timeline.
Key Players
Some of the key players in the global biopharmaceutical
excipients market are Merck KGaA (Germany), Colorcon (BPSI Holdings Inc) (US),
BASF SE(Germany), Associated British Foods plc (UK), Signet Excipients Pvt. Ltd
(IMCD) (Netherlands), Sigachi Industries Limited (Hyderabad), Spectrum Chemical
Manufacturing Corp. (US), Roquette Frères (France), Clariant (Switzerland), DFE
Pharma (Germany), J. Rettenmaier & Söhne Gmbh + Co Kg (Germany), and Evonik
Industries AG (Germany).
Regional Analysis
North America is projected to dominate the biopharmaceutical
excipients market report due to the growing adoption of the latest drug
manufacturing technologies, increasing chronic diseases, and expansion of
production capabilities of the industry players across the region. In addition,
highinvestments were made in the development of new excipient variants to
advance the product portfolio. Furthermore, the key players are involved in
collaborations, mergers, and R&D activities that propel market
growth.
Europe embraces the second-largest position in the
biopharmaceutical excipients market due to growing investments in the
pharmaceutical sector and increasing production capacity across the region. In
addition, the region experienced high demands for pharmaceutical products.
Moreover, countries such asGermany, Italy, the UK, France, and Spain have
invested huge amounts in the manufacturing of new vaccines.
Asia-Pacific is anticipated to be the fastest-growing
regional market over the projected timeline due to the rising investment in
pharmaceutical research and production facilities, increasing consumption of
medicines, and supportive government alliances and subsidy schemes. In
addition, the availability of highly skilled research employees and an
economical workforce is creating opportunities for the industry players.
Furthermore, the market in the Rest of the World is gaining
importance due to the rising number of investors, growing geriatric population
in countries such as Chile and Argentina, and expansion of the pharmaceutical
market across Latin America. However, the availability of counterfeit pharmaceutical
goods is hampering the biopharmaceutical excipient market. The pharmaceutical
companies aim atinvesting in the Middle East & Africaregion owing to its
technologically advanced labs and other research infrastructures. Countries
such as Saudi Arabia and the UAE are hiring employees throughout the globe to
advance their pharmaceutical market.
Segmentation
The global biopharmaceutical excipients market is
categorized into product and formulation. Based on the product category, the
market has been segregated into solubilizers & surfactants/emulsifiers,
polyols and carbohydrates, and specialty excipients. The carbohydrates segment
is expected to hold a considerable share of the market in 2021. Increasing
R&D activities for the development of lipid and protein excipient-based
corona vaccines is fueling the market demand. In addition, the high demand for
carbohydrate-based medicines for the infant segment is propelling the
biopharmaceutical excipient market.
Based on formulation, the global biopharmaceutical
excipients market has been classified as oral, topical, and injectables. The
oral segmentheld the major share in 2020 due to the easy intake procedure and
availability of oral medicines throughout the hospitals and retail stores.
Additionally, the demand for oral and topical formulations is accelerating due
to the growing preference for on-the-go treatment and ambulatory treatment
services coupled with increasing cases of trypanophobia.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Dental Amalgam has long been the popular
cavity filling choice for dentists because of its strength and durability. A
cavity is a common dental problem caused by a build-up of plaque, a sticky
substance made up of bacteria. Due to the widespread cavity concerns, dental
amalgam witnesses a huge demand all over the world. Resultantly, the dental
amalgam market is growing pervasively on the global platform.
Considering the kind of the growth, the
market perceives currently, Market Research Future (MRFR) in its recently
published study report asserts that The Dental Amalgam Market will
obtain a market valuation of USD 500 million by 2027 and a CAGR of 5 % in the
forecast period 2022 to 2030.
Dental
Amalgam Market Overview analysis by particle shape, particle size, metals, number
of alloy metals and Forecast to 2030
Silver amalgam fillings that have been a
staple of dentistry since decades consist of approximately 50 percent mercury,
a known toxin that can cause harmful effects in humans. Despite the presence of
mercury, the U.S. FDA considers amalgam fillings safe for adults and children
over six years old.
Composite amalgam offers a reliable,
durable, and aesthetics alternative for small- to medium-sized cavities,
creating a better seal. Performance characteristics of composite amalgam have
improved over the years to now rank as the most popular option. The ability to
closely match the color to natural teeth makes composites a viable option for
both front and back teeth.
Key Players:
Some of the eminent leaders of the market
include Patterson Dental, DMP Dental, APL Materials, Nanjing FoiNoe Co., Ltd.,
DMP, AT&M Biomaterials Co., Ltd., Kerr Corporation, BOME, Benco Dental
Supply Company, and Henry Schein, Inc.
Besides, composites offer superior bonding
capabilities to the tooth structure. The emergence of composite fillings has
given rise to the market, increasingly encouraging people to opt for the
Amalgam, which in turn, augments the market demand for dental
amalgam.
The cosmetic dentistry treatment market
also supports the dental amalgam market. Furthermore, growing oral
healthcare concerns worldwide, fuel the market growth predominantly. Increasing
awareness among people about oral health plays a major role in fostering the
market growth.
Additional factors substantiating the
market growth include the growing population including increasing geriatric
populace and urbanization. Improving economic conditions across the globe
provide impetus to the market growth, enabling access to the quality of life
with the improving healthcare. Seminal efforts and investments by the market
players to develop innovative Amalgam materials and to bring betterment in
their existing materials are paying off well, driving the market growth.
On the other hand, factors such as
inadequate reimbursements for dental amalgam are expected to inhibit the market
growth, especially in the developed economies. Nevertheless, the emergence of
cost-competitive composite amalgam material is expected to support the market
growth.
Global Dental Amalgam Market –
Segmentations
By Particle Shape :Lath Cut Particles, Spherical
Particles, and Admixed Particles among others.
By Particle Size:Micro Cut, Fine Cut, and Coarse Cut
among others.
By Metals:
Noble Metals (gold, silver, other),
and Non-noble Metals (copper, gallium, others) among others.
By Number of Alloy Metals: Binary Alloy, Ternary Alloy, and
Quaternary Alloy among others.
By Regions: North America, Europe, APAC and
Rest-of-the-World.
Global Dental Amalgam Market –
Geographical Analysis
Geographically, the North American region accounts
for the leading market for dental amalgam, capturing the largest market share
followed by the European & Asia Pacific region, respectively. High
expenditure on health care is the main driving force for the market growth in
North America. Moreover, burgeoning market in the US backed by the substantial
investments significantly contributes to the market growth in the region.
Additionally, increasing demand for dental
amalgam due to the prevailing dental problems such as tooth decay provides
impetus to the market growth. Continuing with the same trends, the North
America dental amalgam market is expected to create a larger revenue pocket in
the global market by 2023.
The European region is the world’s
second-largest market for dental amalgam. The market is driven by the high per
capita health care expenditures and well-established healthcare sector in the
region. Countries such as the UK, Germany, and France backed by the huge
investments drive the regional market growth at a large scale. With the increasing
investment in health care and the rising number of patients with dental
diseases, the dental amalgam market in Europe is projected to register a
phenomenal CAGR during the assessment period.
The Asia Pacific dental
amalgam market Report is expected to perceive an exponential growth,
emerging as a promising market for the product. Growing markets of India &
China backed by the vast population and the burgeoning medical treatment foster
the market growth in the region. Furthermore, Vietnam, Thailand, and Malaysia
among the other South East Asian countries are projected to contribute
significantly to the regional market growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Insights
Increasing diagnoses of AML are due to exposure to
carcinogenics which are present everywhere. Changing lifestyles have given rise
to unhealthy habits which lead to cancer. AML can also be passed genetically,
and increased prevalences of cancer combined with the growing population drive
the market. Other key factors of note which are affecting the market include
improving reimbursement policies, and increasing number of cancer hospitals
staffed with specialists to specifically treat cancers like AML. Supportive
funding for research and development of treatment for this swiftly progressing
diseases is expected to offer various opportunities for growth. Awareness
regarding actual myeloid leukemia has been observed to be increasing and is
likely to increase diagnoses and lead to growth over the forecast period.
However, the side effects associated with drugs used for treatment currently
and the availability of effective medication are challenging the growth of the
market.
The Acute
Myeloid Leukemia Treatment Market Trends will register a CAGR of approx
8.80% and is expected to reach USD 29.12 Billion during the forecast period
2022-2030. This type of cancer is comparatively rare and progresses at a
rapid pace thus creating significant demand for effective treatment and
diagnostic options.
Market Segmentation
The global acute myeloid leukemia treatment market is
segmented on the basis of disease type, treatment, and region. By disease type,
the market is segmented into promyelocytic, myeloblastic, myelomonocytic, monocytic,
megakaryocytic and erythroleukemia.
By treatment, the market is segmented into chemotherapy and
hematopoietic stem cell transplantation. The chemotherapy segment is further
segmented into post remission and induction.
The regional segmentation of the AML treatment market
divides the globe into North America, Europe, Asia Pacific and the Middle East
and Africa.
Regional Analysis
Led by the US, North America accounts for the largest share
of the global market. The presence of various market-leading players and
increasing investments in R&D for drug development drives the market. The
region has favorable reimbursement policies and high healthcare expenditure
which bring it to the forefront of the global acute
myeloid leukemia treatment market report. Europe follows the North American
market due to a large number of hospitals present in the region combined with
high disposable incomes. North America and Europe follow similar growth
patterns.
The Asia Pacific is expected to grow at the highest CAGR
during the review period due to large unmet potential present in the region.
Countries such as India and China are anticipated to drive demand for AML
treatment. The rapid growth in the region's economy combined with a growing
demand for advanced healthcare is expected to encourage considerable growth for
the APAC.
Key Players
The competitive analysis of the global AML market reveals
key strategies used by various leading market players. Prominent players
included in the report are Ambit Biosciences Corporation, Novartis AG, Sanofi,
Cyclacel Pharmaceuticals Inc., Bristol Myers Squibb, Celgene Corporation,
Johnson & Johnson, and Pfizer Inc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Synopsis:
Electrotherapy is a type of treatment in
which electrical impulses are used in stimulating nerves and muscles for
multiple purposes which majorly includes pain management, stimulation of muscle
contraction, stimulation of physiochemical changes in the body and
others.
The use of electrotherapy for various
therapeutic purposes is increasing, hence driving the growth of the global
electrotherapy market. Market Research Future (MRFR), a firm that excels in
healthcare sector among others, has recently published a report on
electrotherapy market asserting that the global The electrotherapy
market Trends is expected to register a CAGR of 5.10% during the assessment
period of 2020 to 2027, to reach USD 1,463.74 million by 2027.
The inclination of physiotherapists and
athletic trainers is more towards the inclusion of electrotherapy system as an
adjunct to the traditional physiotherapy treatment. The rapid adoption of
advanced technology in the healthcare sector is increasing the demand for electrotherapy
system in the market. The increase in the incidence of spinal injuries and
growing prevalence of diabetes and obesity are some of the factors fuelling the
expansion of global electrotherapy market. The rapid inclusion of
electrotherapy system for re-education after nerve injury or trauma, to reduce
muscle damage due to immobilization and to increase the production of vitamin D
and corticosteroids is driving the global electrotherapy market to reach higher
verticals.
Electrotherapy is believed to stimulate the
intracellular activities in the body leading to faster healing of wounds. It is
widely used in sports and athletics sector by trainers and physiotherapist as a
pain management treatment to alleviate the pain in 5 to 30 minutes depending on
the degree of injury. The augmentation in technological advancement and
increasing dependency on advanced healthcare procedures to provide or receive
efficient and quick remedies is one of the major factors that are driving the
global electrotherapy market. On the flip side, lack of usage guidelines,
availability of substitute products and low awareness regarding the available
treatments are likely to hamper the growth of global electrotherapy market.
Key Players of Global Electrotherapy
Market:
Some of the prominent players in the global
electrotherapy market are BTL (Czech Republic), Eme Srl (Italy), EMS Physio
Ltd. (UK), Enraf-Nonius B.V.(Netherlands), gbo Medizintechnik AG (Germany),
MEDTRONIC (Republic of Ireland), Omron Healthcare, Inc.(US), Phoenix Healthcare
(UK), Pure Care (US), STYMCO Technologies, LLC (US), Walgreen Co. (US), and
others.
Market Segmentation:
The Global Electrotherapy
Market Report has been segmented on the basis of type, devices and
application. On the basis of types, the electrotherapy market is segmented into
extracorporeal shock wave therapy, interferential, magnetic field therapy
(constant energy magnets, pulsed electro-magnetic field energy), ultrasound
therapy, transcutaneous electrical nerve stimulation (TENS) therapy (conventional
TENS, acupuncture-like TENS (AL-TENS), intense TENS), and others.
On the basis of devices, the global
electrotherapy market is segmented into transcutaneous electrical neural
stimulator (TENS), electronic muscle stimulator (EMS), interferential
stimulator (IF), high voltage pulsed galvanic stimulator (HVPGS), micro-current
stimulator (MC) or micro-current electrical neuromuscular stimulator (MENS),
and others.
On the basis of application, the global
electrotherapy market is segmented into orthopedics, cardiology, urology, pain
management (chronic pain, chronic fatigue, migraine headaches, wound healing,
diabetic nerve pain, stimulating bone growth), acute and chronic edema, and
others.
Detailed Regional Analysis:
Regionally, the global electrotherapy
market is segmented into North America, Europe, Asia-Pacific (APAC) and Middle
East and Africa. Due to the increasing adoption of electrotherapy system in
sports injury treatments and other purposes, North America is currently the
largest market for electrotherapy. The use of electrotherapy as rehabilitation
and preventive tool for partially or completely immobilized patients is driving
the market in the European region. On the other hand, Asia-Pacific region is
considered to be the fastest growing electrotherapy market and it may out-run
North America for being the largest market by the end of 2023. Whereas,
Middle-East and Africa are likely to have limited growth in the electrotherapy
market due to the lack of awareness of the treatment and devices.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Malaria is a life-threatening disease that is transmitted
through the bite of infected anopheles mosquitos. The infected mosquitos
transmit the plasmodium parasite into the bloodstream of human body upon being
bitten. As the parasite enters the human body, it travels around the body to
affect the liver and matures with time. Upon attaining maturity, the parasite
enters the bloodstream to infect the red blood cells in the body. This causes
individuals suffering from malaria to frequently experience headache, vomiting,
fever, and weakness.
Africa Malaria
Diagnosis & Treatment Market Overview analysis, by Diagnosis (Rapid
Diagnostic Tests (RDT’s), Molecular diagnostics, Microscopy), by Malarial
Parasite (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae and
Plasmodium Ovale) - Forecast till 2030
The Africa malaria diagnosis & treatment market is
projected to reach USD 2,467.6 Million by 2030 at 6.9% CAGR during the forecast
period 2022-2030.It is reported in a study released by Market Research Future
(MRFR), that the market is positively influenced by a number of factors. A
major factor influencing this growth is the increasing advancements in
technology related to diagnostic tools and the proliferating demand for such
treatments in malaria-endemic countries. Other factors driving the market
growth are rising support from the government in terms of investment funds and
an increase in the collaboration between the research centers and the industry.
Malaria diagnostic tests play a significant role in identifying malarial cases,
which thereby boosts the growth of the overall malaria diagnostic market.
However, the lack of precise monitoring standards at
developing nations, acts as a major factor constraining the market. The lack of
awareness among emerging nations and work regulatory framework is of particular
concern for both manufacturers and healthcare providers.
Market Segmentation
The global malaria diagnostics market segmentation is done
as per technology and end-user.
By technology, the market is divided into microscopy,
molecular diagnostic tests, and rapid diagnostic tests. Furthermore, the
molecular diagnostic test is narrowed down into real-time polymerase chain
reaction (RT-PCR) and polymerase chain reaction (PCR).
By end-users, the market comprises of clinics, hospitals,
community healthcare, and others.
Regional Analysis
Geographically, the global malaria diagnostic market covers
regions such as North America, European, Asia Pacific, and Middle East &
Africa.
The North American region holds the largest share of the malaria
diagnostic market Report and leads the global standings. The region is
further expected to garner the largest market share during the forecast period
2018 and 2023. The market is slated for growth due to the rise in awareness,
advancing medical technologies, favorable compensation setting for various
surgical methods and procedures, medical tourism, and expanding growth of the
healthcare sector.
Competitive Landscape
The global malaria diagnostics market comprises of a number
of key and prominent players, including Leica Microsystems GmbH, Premier
Medical Corporation Pvt. Ltd, Access Bio. Inc., Beckman Coulter Inc.,
bioMérieux, Nikon Corporation, Abbott Laboratories, Olympus Corporation, Sysmex
Partec GmbH, Siemens Healthineers, and Bio-Rad Laboratories Inc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Vaccination is encouraged by governments and institutions as
it enhances immunity against diseases, yet, there is insufficient vaccination
coverage in Middle East & Africa market. The persisting vastness of this
gap between demand and supply will drive the market growth for the next few
years. Market Research Report (MRFR) has revealed in its latest the human
vaccines market Report in Middle East & Africa will reach a record
level of USD 5.46 Bn by 2022 from USD 2.8 Bn in 2015. The market will exhibit a
robust CAGR of 11.8% across the projection period.
The hindrances to market growth that overshadows immense
potential exhibited by the market to some extent are – lack of awareness, side
effects of vaccination, declining profitability in vaccine manufacturing,
eradication of diseases, difficulty in producing vaccines for microbes with
high mutations such as HIV, etc.
Regional Analysis:
The most significant share of revenue in Middle East &
Africa region will be generated from U.A.E. due to its speeding pace of
development in the healthcare sector, rapid urbanization, rise in healthcare
expenditure, etc. The growing awareness about the diseases and the possibility
of prevention has catapulted the demand in the region. Egypt trails U.A.E’s
share of revenue contribution and is expected to retain its position for the
next six years.
The market in Africa holds tremendous potential for growth
as there is a massive gap between the need and access which will catalyze the
demand in the market for the next few years. Furthermore, the frequent outbreak
of diseases and significant death rate due to lack of proper vaccination has
motivated the organizations such as World Health Organization (WHO) to
undertake initiatives and spiral market expansion. According to WHO, in Africa,
30 million children under-five age group fall sick due to diseases that can be
prevented through proper vaccination, and of these, over half a million die.
Owing to the poor vaccination coverage, the market in Africa is expected to
grow at the fastest pace, especially in Sub Saharan regions.
Competitive Dashboard:
The key players profiled by Market Research Future (MRFR) in
its report are Merck & Co. Inc., Sanofi Pasteur, Inc., Bharat Biotech,
Valeant Pharmaceuticals, AstellasPharma Inc., GlaxoSmithKline Plc., Pfizer,
Inc., AstraZeneca Plc., Shenzhen Kangtai Biological Products, Emergent
Biosolutions Inc., and, Panacea Biotec. The players strive to penetrate the
market and tap the unexplored opportunities available in the market by the
employment of strategies such as collaboration with government institutions,
widening access of vaccines in remote areas, creating awareness, etc.
Human Vaccines Market Segmentation:
By technology, the human
vaccines market Trends in Middle East & Africa has been segmented into
attenuated, inactivated, toxoid, conjugate & subunit, and, recombinant DNA.
By disease indication, the human vaccines market is
segmented into pneumococcal, influenza, hepatitis, rotavirus, DTP, polio, and,
others.
By type, the market for human vaccines has been segmented
into prophylactic and therapeutic.
By composition, the market has been segmented into mono
vaccine and combination vaccines.
By end user, the market is segmented into children and
adults.
By route of administration, the market has been segmented
into oral, injectable and other.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.